Eagle Health Investments LP Sells 3,000 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Eagle Health Investments LP reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 40.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,390 shares of the medical equipment provider's stock after selling 3,000 shares during the period. Intuitive Surgical accounts for about 0.6% of Eagle Health Investments LP's holdings, making the stock its 15th biggest position. Eagle Health Investments LP's holdings in Intuitive Surgical were worth $2,291,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ISRG. NEOS Investment Management LLC increased its position in shares of Intuitive Surgical by 24.4% during the fourth quarter. NEOS Investment Management LLC now owns 44,979 shares of the medical equipment provider's stock valued at $23,477,000 after acquiring an additional 8,832 shares during the last quarter. UniSuper Management Pty Ltd increased its position in shares of Intuitive Surgical by 8.8% during the 4th quarter. UniSuper Management Pty Ltd now owns 59,354 shares of the medical equipment provider's stock valued at $30,980,000 after purchasing an additional 4,793 shares during the last quarter. Sava Infond d.o.o. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $4,979,000. WINTON GROUP Ltd purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $1,021,000. Finally, Artisan Partners Limited Partnership grew its position in Intuitive Surgical by 8.8% during the fourth quarter. Artisan Partners Limited Partnership now owns 156,551 shares of the medical equipment provider's stock valued at $81,713,000 after buying an additional 12,660 shares during the period. 83.64% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

A number of research analysts have weighed in on ISRG shares. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 0.0 %

Shares of NASDAQ:ISRG traded down $0.09 on Monday, reaching $491.75. 806,866 shares of the company traded hands, compared to its average volume of 1,524,313. The stock has a market capitalization of $175.15 billion, a P/E ratio of 76.87, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business's 50-day simple moving average is $556.28 and its 200 day simple moving average is $532.97. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.